CURX vs INTS
Comparison between Curanex Pharmaceuticals Inc (CURX, Company) and Intensity Therapeutics Inc (INTS, Company).
Both CURX and INTS are from the Healthcare sector.
CURX vs INTS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
CURX
$9.50M
INTS
$9.50M
Max Drawdown
Winner
CURX
97.07%
INTS
98.53%
Sharpe Ratio
CURX
-0.92
Winner
INTS
0.53
5Y Beta
CURX
1.31
Winner
INTS
-0.44
Industry
CURX
Biotechnology
INTS
Biotechnology
P/E Ratio
Winner
CURX
-1.31
INTS
-0.63
Debt to Equity
CURX
0.00%
INTS
0.00%
Free Cash Flow Yield
CURX
N/A
INTS
-95.46%
P/B Ratio
CURX
N/A
INTS
1.01
CURX vs INTS - Historical Returns
Returns include dividend reinvestment.
1M
Winner
CURX
+11.37%
INTS
-19.76%
3M
Winner
CURX
-17.79%
INTS
-43.37%
6M
Winner
CURX
-11.84%
INTS
-64.99%
1Y
CURX
-91.67%
Winner
INTS
-48.58%
Max(CAGR)
CURX
-95.39%
Winner
INTS
-71.31%
CURX vs INTS - Annual Returns (2023 - 2026)
Returns include dividend reinvestment.
| Year | CURX | INTS |
|---|---|---|
| 2026 | -9.04% | -63.88% |
| 2025 | -91.78% | -76.56% |
| 2024 | N/A | -79.70% |
| 2023 | N/A | +43.79% |
CURX vs INTS Drawdown Comparison
The maximum drawdown for CURX was -97.07%, occurring on Feb 5, 2026. This drawdown has not yet recovered.
The maximum drawdown for INTS was -98.53%, occurring on Jun 12, 2026. This drawdown has not yet recovered.
The current CURX drawdown is -96.34%. The current INTS drawdown is -98.51%.
| Rank | CURX | INTS |
|---|---|---|
| #1 | -97.07% Sep 16, 2025 - Feb 5, 2026 | -98.53% Dec 13, 2023 - Jun 12, 2026 |
| #2 | -1.92% Sep 12, 2025 - Sep 16, 2025 | -67.49% Jul 18, 2023 - Dec 8, 2023 |
| #3 | -1.77% Sep 9, 2025 - Sep 11, 2025 | -8.87% Jul 3, 2023 - Jul 18, 2023 |
Correlation
Correlation between CURX and INTS is -0.04 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.04
-101
Select Stocks to Compare
Popular: CURX vs SPYINTS vs SPY
More Comparisons
Compare with similar stocks